Option Care Health, Inc. (OPCH)
USD 31.98
(1.38%)
USD 31.98
(1.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 822.56 Million USD | 4.2% |
| 2022 | 789.39 Million USD | -16.06% |
| 2021 | 940.47 Million USD | -7.42% |
| 2020 | 1.01 Billion USD | -16.06% |
| 2019 | 1.21 Billion USD | 146.91% |
| 2018 | 490.13 Million USD | 11.11% |
| 2017 | 441.13 Million USD | -0.28% |
| 2016 | 442.36 Million USD | 5.73% |
| 2015 | 418.4 Million USD | -1.1% |
| 2014 | 423.06 Million USD | -2.65% |
| 2013 | 434.57 Million USD | 164.54% |
| 2012 | 164.27 Million USD | -44.02% |
| 2011 | 293.45 Million USD | -4.25% |
| 2010 | 306.46 Million USD | 833.62% |
| 2009 | 32.82 Million USD | -34.88% |
| 2008 | 50.41 Million USD | 49.24% |
| 2007 | 33.77 Million USD | -36.14% |
| 2006 | 52.89 Million USD | 795.61% |
| 2005 | 5.9 Million USD | 34.81% |
| 2004 | 4.38 Million USD | 148.71% |
| 2003 | -8.99 Million USD | -12391.67% |
| 2002 | -72 Thousand USD | 99.34% |
| 2001 | -10.86 Million USD | -1098.35% |
| 2000 | 1.08 Million USD | 106.66% |
| 1999 | -16.33 Million USD | -683.39% |
| 1998 | 2.8 Million USD | 132.56% |
| 1997 | -8.6 Million USD | -616.67% |
| 1996 | -1.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 848.59 Million USD | -10.79% |
| 2024 Q3 | 628.59 Million USD | -12.98% |
| 2024 Q1 | 951.18 Million USD | 15.64% |
| 2023 FY | 822.56 Million USD | 4.2% |
| 2023 Q1 | 760.01 Million USD | -3.72% |
| 2023 Q4 | 822.56 Million USD | 22.67% |
| 2023 Q3 | 670.52 Million USD | 8.81% |
| 2023 Q2 | 616.22 Million USD | -18.92% |
| 2022 Q1 | 1.01 Billion USD | 7.82% |
| 2022 FY | 789.39 Million USD | -16.06% |
| 2022 Q2 | 953.32 Million USD | -5.99% |
| 2022 Q4 | 789.39 Million USD | -12.31% |
| 2022 Q3 | 900.24 Million USD | -5.57% |
| 2021 Q3 | 1.01 Billion USD | -4.0% |
| 2021 Q1 | 1.11 Billion USD | 9.34% |
| 2021 FY | 940.47 Million USD | -7.42% |
| 2021 Q4 | 940.47 Million USD | -7.73% |
| 2021 Q2 | 1.06 Billion USD | -4.4% |
| 2020 Q2 | 1.23 Billion USD | -3.62% |
| 2020 Q1 | 1.28 Billion USD | 5.95% |
| 2020 Q3 | 1.02 Billion USD | -17.24% |
| 2020 FY | 1.01 Billion USD | -16.06% |
| 2020 Q4 | 1.01 Billion USD | -0.68% |
| 2019 Q1 | 530.09 Million USD | 8.15% |
| 2019 FY | 1.21 Billion USD | 146.91% |
| 2019 Q3 | 1.29 Billion USD | 142.34% |
| 2019 Q2 | 535.43 Million USD | 1.01% |
| 2019 Q4 | 1.21 Billion USD | -6.73% |
| 2018 FY | 490.13 Million USD | 11.11% |
| 2018 Q4 | 490.13 Million USD | 2.13% |
| 2018 Q1 | 451.08 Million USD | 2.26% |
| 2018 Q2 | 472.44 Million USD | 4.74% |
| 2018 Q3 | 479.9 Million USD | 1.58% |
| 2017 Q2 | 436.87 Million USD | -4.31% |
| 2017 Q4 | 441.13 Million USD | -1.0% |
| 2017 Q1 | 456.52 Million USD | 3.2% |
| 2017 FY | 441.13 Million USD | -0.28% |
| 2017 Q3 | 445.56 Million USD | 1.99% |
| 2016 FY | 442.36 Million USD | 5.73% |
| 2016 Q1 | 415.87 Million USD | -0.6% |
| 2016 Q4 | 442.36 Million USD | 2.07% |
| 2016 Q3 | 433.4 Million USD | 24.53% |
| 2016 Q2 | 348.03 Million USD | -16.31% |
| 2015 Q2 | 417.68 Million USD | 5.59% |
| 2015 Q1 | 395.58 Million USD | -6.5% |
| 2015 FY | 418.4 Million USD | -1.1% |
| 2015 Q4 | 418.4 Million USD | -0.25% |
| 2015 Q3 | 419.47 Million USD | 0.43% |
| 2014 Q3 | 423.28 Million USD | 1.46% |
| 2014 Q1 | 409.41 Million USD | -5.79% |
| 2014 Q4 | 423.06 Million USD | -0.05% |
| 2014 FY | 423.06 Million USD | -2.65% |
| 2014 Q2 | 417.19 Million USD | 1.9% |
| 2013 Q2 | 143.85 Million USD | -43.22% |
| 2013 Q3 | 415.6 Million USD | 188.91% |
| 2013 FY | 434.57 Million USD | 164.54% |
| 2013 Q1 | 253.36 Million USD | 54.23% |
| 2013 Q4 | 434.57 Million USD | 4.56% |
| 2012 Q4 | 164.27 Million USD | 3.15% |
| 2012 Q1 | 291.37 Million USD | -0.71% |
| 2012 FY | 164.27 Million USD | -44.02% |
| 2012 Q2 | 119.02 Million USD | -59.15% |
| 2012 Q3 | 159.26 Million USD | 33.81% |
| 2011 FY | 293.45 Million USD | -4.25% |
| 2011 Q4 | 293.45 Million USD | 5.21% |
| 2011 Q3 | 278.92 Million USD | 2.05% |
| 2011 Q2 | 273.31 Million USD | -1.56% |
| 2011 Q1 | 277.63 Million USD | -9.41% |
| 2010 Q2 | 286.63 Million USD | -3.26% |
| 2010 Q4 | 306.46 Million USD | 14.51% |
| 2010 Q3 | 267.63 Million USD | -6.63% |
| 2010 FY | 306.46 Million USD | 833.62% |
| 2010 Q1 | 296.3 Million USD | 802.65% |
| 2009 Q2 | 33.06 Million USD | -8.44% |
| 2009 Q1 | 36.11 Million USD | -28.36% |
| 2009 Q4 | 32.82 Million USD | -17.07% |
| 2009 FY | 32.82 Million USD | -34.88% |
| 2009 Q3 | 39.58 Million USD | 19.71% |
| 2008 Q2 | 19.81 Million USD | -59.16% |
| 2008 Q3 | 55.02 Million USD | 177.74% |
| 2008 Q4 | 50.41 Million USD | -8.38% |
| 2008 FY | 50.41 Million USD | 49.24% |
| 2008 Q1 | 48.5 Million USD | 43.61% |
| 2007 Q4 | 33.77 Million USD | -6.58% |
| 2007 Q3 | 36.15 Million USD | -13.63% |
| 2007 Q2 | 41.86 Million USD | -16.58% |
| 2007 Q1 | 50.18 Million USD | -5.13% |
| 2007 FY | 33.77 Million USD | -36.14% |
| 2006 FY | 52.89 Million USD | 795.61% |
| 2006 Q2 | 34.09 Million USD | 35.38% |
| 2006 Q3 | 45.37 Million USD | 33.07% |
| 2006 Q1 | 25.18 Million USD | 326.41% |
| 2006 Q4 | 52.89 Million USD | 16.58% |
| 2005 Q3 | 14.41 Million USD | 136.83% |
| 2005 Q4 | 5.9 Million USD | -59.02% |
| 2005 Q2 | 6.08 Million USD | 147.62% |
| 2005 Q1 | -12.77 Million USD | -391.67% |
| 2005 FY | 5.9 Million USD | 34.81% |
| 2004 FY | 4.38 Million USD | 148.71% |
| 2004 Q3 | 5.04 Million USD | -39.42% |
| 2004 Q2 | 8.32 Million USD | -33.35% |
| 2004 Q1 | 12.48 Million USD | 238.84% |
| 2004 Q4 | 4.38 Million USD | -13.11% |
| 2003 FY | -8.99 Million USD | -12391.67% |
| 2003 Q4 | -8.99 Million USD | -304.77% |
| 2003 Q1 | 216 Thousand USD | 400.0% |
| 2003 Q2 | -4.67 Million USD | -2264.81% |
| 2003 Q3 | -2.22 Million USD | 52.48% |
| 2002 FY | -72 Thousand USD | 99.34% |
| 2002 Q3 | 3.97 Million USD | -56.73% |
| 2002 Q2 | 9.18 Million USD | -49.54% |
| 2002 Q4 | -72 Thousand USD | -101.81% |
| 2002 Q1 | 18.2 Million USD | 267.58% |
| 2001 Q4 | -10.86 Million USD | -3177.05% |
| 2001 Q2 | 1.24 Million USD | 18.97% |
| 2001 Q1 | 1.04 Million USD | -3.58% |
| 2001 FY | -10.86 Million USD | -1098.35% |
| 2001 Q3 | 353 Thousand USD | -71.71% |
| 2000 Q4 | 1.08 Million USD | -59.05% |
| 2000 Q1 | -18.12 Million USD | -10.98% |
| 2000 Q2 | -16.53 Million USD | 8.82% |
| 2000 Q3 | 2.65 Million USD | 116.07% |
| 2000 FY | 1.08 Million USD | 106.66% |
| 1999 FY | -16.33 Million USD | -683.39% |
| 1999 Q2 | -3.7 Million USD | -3800.0% |
| 1999 Q3 | -11.6 Million USD | -213.51% |
| 1999 Q4 | -16.33 Million USD | -40.82% |
| 1999 Q1 | 100 Thousand USD | -96.43% |
| 1998 Q4 | 2.8 Million USD | 158.33% |
| 1998 Q3 | -4.8 Million USD | -166.67% |
| 1998 FY | 2.8 Million USD | 132.56% |
| 1998 Q1 | -4.9 Million USD | 43.02% |
| 1998 Q2 | -1.8 Million USD | 63.27% |
| 1997 Q1 | -7.4 Million USD | -516.67% |
| 1997 Q3 | -5 Million USD | -138.1% |
| 1997 Q4 | -8.6 Million USD | -72.0% |
| 1997 FY | -8.6 Million USD | -616.67% |
| 1997 Q2 | -2.1 Million USD | 71.62% |
| 1996 Q3 | -47.9 Million USD | 0.0% |
| 1996 FY | -1.2 Million USD | 0.0% |
| 1996 Q4 | -1.2 Million USD | 97.49% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 41.689% |
| Addus HomeCare Corporation | 110.39 Million USD | -645.136% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -820.031% |
| Amedisys, Inc. | 341.35 Million USD | -140.973% |
| American Oncology Network, Inc. | 99.78 Million USD | -724.327% |
| Astrana Health, Inc. | 27.2 Million USD | -2923.351% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 43.476% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 371441.83% |
| biote Corp. | 25.86 Million USD | -3079.725% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -7741.429% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 7054.959% |
| COMPASS Pathways plc | -187.58 Million USD | 538.494% |
| DocGo Inc. | -12.78 Million USD | 6531.799% |
| The Ensign Group, Inc. | 1.36 Billion USD | 39.592% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 7791.099% |
| InnovAge Holding Corp. | 56.08 Million USD | -1366.532% |
| Assure Holdings Corp. | 14.68 Million USD | -5502.527% |
| The Joint Corp. | -2.47 Million USD | 33275.087% |
| LifeStance Health Group, Inc. | 432.21 Million USD | -90.312% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 13694.82% |
| ModivCare Inc. | 1.13 Billion USD | 27.673% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -295308.854% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -20183.523% |
| P3 Health Partners Inc. | 83.7 Million USD | -882.669% |
| P3 Health Partners Inc. | 83.7 Million USD | -882.669% |
| The Pennant Group, Inc. | 323.57 Million USD | -154.212% |
| Surgery Partners, Inc. | 2.86 Billion USD | 71.296% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 27229.637% |
| Talkspace, Inc. | -123.9 Million USD | 763.85% |
| Talkspace, Inc. | -123.9 Million USD | 763.85% |
| The Oncology Institute, Inc. | 86.32 Million USD | -852.846% |
| The Oncology Institute, Inc. | 86.32 Million USD | -852.846% |